Patent · US Expired

Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor

US7071182B2 · kind B2 · utility

1Cited by

0References

19Claims

0Family size

Assignee

Abbott Laboratories · US

Inventors

Andrew J. Souers · Libertyville, US
Christine Collins · Skokie, US
Ju Gao · Gurnee, US
Andrew S. Judd · Grayslake, US
Philip R. Kym · Libertyville, US
Mathew M. Mulhern · Hainesville, US
Hing L. Sham · South San Francisco, US
Dariusz Wodka · Waukegan, US

Key dates

Filing date	Dec 22, 2004
Grant date	Jul 4, 2006
Priority date	—
Expiry date	Dec 22, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.